---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-010853"
form_type: "8-K"
ticker: "TCMD"
cik: "0001027838"
company_name: "TACTILE SYSTEMS TECHNOLOGY INC"
filed_at: "2024-08-05T23:59:59+00:00"
generated_at: "2026-05-31T12:56:23.708303+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Tactile Medical Q2 revenue $73.2M (+7% YoY); lowers FY 2024 guidance to $293-298M

## Summary
- Revenue of $73.2M, up 7% YoY; lymphedema product revenue +8%, airway clearance +2%.
- Net income of $4.3M ($0.18 diluted EPS) vs net loss of $0.1M in Q2 2023; adjusted EBITDA $9.1M.
- Full-year 2024 revenue guidance lowered to $293-298M (7-9% growth) from prior $300-305M (9-11%).
- Appointed Sheri Dodd as President and CEO effective July 1, 2024; received 510(k) clearance for Nimbl system.

## SEC filing metadata
- accession: 0001558370-24-010853
- form_type: 8-K
- ticker: TCMD
- cik: 0001027838
- company_name: TACTILE SYSTEMS TECHNOLOGY INC
- filed_at: 2024-08-05T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1027838/000155837024010853/0001558370-24-010853-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1027838/000155837024010853/tcmd-20240805x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-010853
- JSON: https://secwatch.observer/filing/0001558370-24-010853.json
- Plain text: https://secwatch.observer/filing/0001558370-24-010853.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.